JP2000514060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000514060A5 JP2000514060A5 JP1998504196A JP50419698A JP2000514060A5 JP 2000514060 A5 JP2000514060 A5 JP 2000514060A5 JP 1998504196 A JP1998504196 A JP 1998504196A JP 50419698 A JP50419698 A JP 50419698A JP 2000514060 A5 JP2000514060 A5 JP 2000514060A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67439196A | 1996-07-01 | 1996-07-01 | |
| US08/674,391 | 1996-07-01 | ||
| PCT/US1997/010696 WO1998000412A1 (en) | 1996-07-01 | 1997-06-26 | Muscarinic antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008194199A Division JP2009040778A (ja) | 1996-07-01 | 2008-07-28 | ムスカリン様アンタゴニスト |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000514060A JP2000514060A (ja) | 2000-10-24 |
| JP2000514060A5 true JP2000514060A5 (enExample) | 2005-03-10 |
Family
ID=24706404
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10504196A Ceased JP2000514060A (ja) | 1996-07-01 | 1997-06-26 | ムスカリン様アンタゴニスト |
| JP2008194199A Pending JP2009040778A (ja) | 1996-07-01 | 2008-07-28 | ムスカリン様アンタゴニスト |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008194199A Pending JP2009040778A (ja) | 1996-07-01 | 2008-07-28 | ムスカリン様アンタゴニスト |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0912534B1 (enExample) |
| JP (2) | JP2000514060A (enExample) |
| KR (1) | KR20000022380A (enExample) |
| AT (1) | ATE224884T1 (enExample) |
| AU (1) | AU717431B2 (enExample) |
| CA (1) | CA2258044C (enExample) |
| DE (1) | DE69715865T2 (enExample) |
| ES (1) | ES2179353T3 (enExample) |
| HU (1) | HUP9904167A3 (enExample) |
| IL (1) | IL127858A0 (enExample) |
| NZ (1) | NZ333322A (enExample) |
| WO (1) | WO1998000412A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726736D0 (en) | 1997-12-18 | 1998-02-18 | Zeneca Ltd | Chemical compounds |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| GB9914015D0 (en) * | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
| WO2000039105A1 (en) * | 1998-12-24 | 2000-07-06 | Astrazeneca Ab | 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders |
| GB9900078D0 (en) * | 1999-01-05 | 1999-02-24 | Zeneca Ltd | Chemical compounds |
| GB9914024D0 (en) * | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
| GB9914022D0 (en) * | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
| GB9914025D0 (en) * | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
| US7067539B2 (en) * | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
| AU2002352124A1 (en) * | 2001-12-03 | 2003-06-17 | F. Hoffmann-La Roche Ag | Aminotetralin derivatives as muscarinic receptor antagonists |
| DE60328033D1 (de) * | 2002-11-25 | 2009-07-30 | Schering Corp | Cannabinoid-rezeptorliganden |
| WO2005037830A1 (en) | 2003-10-10 | 2005-04-28 | Wyeth | Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| US7678798B2 (en) | 2004-04-13 | 2010-03-16 | Incyte Corporation | Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| US7378415B2 (en) | 2004-09-30 | 2008-05-27 | Roche Palo Alto Llc | Benzoxazine and quinoxaline derivatives and uses thereof |
| AU2005318595B2 (en) * | 2004-12-21 | 2011-03-03 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
| JP2008535824A (ja) * | 2005-03-29 | 2008-09-04 | ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー | 置換アミノアルキルベンゾピラン誘導体およびアミドアルキルベンゾピラン誘導体 |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| AU2006310612A1 (en) | 2005-11-03 | 2007-05-10 | F. Hoffmann-La Roche Ag | Arylsulfonylchromans as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors |
| CN101472883A (zh) | 2006-06-20 | 2009-07-01 | 弗·哈夫曼-拉罗切有限公司 | 芳基磺酰氨基四氢萘衍生物以及其应用 |
| BRPI0713736A2 (pt) | 2006-06-20 | 2014-11-18 | Hoffmann La Roche | Derivados de tetralina e indano e emprego destes |
| CA2654822A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Arylsulfonyl naphthalene derivatives and uses thereof |
| WO2010081851A1 (en) | 2009-01-14 | 2010-07-22 | Genoscience Pharma | Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
| IN2012DN06631A (enExample) | 2010-02-16 | 2015-10-23 | Pfizer | |
| WO2017015349A1 (en) * | 2015-07-20 | 2017-01-26 | Chase Pharmaceuticals Corporation | Muscarinic combination of a selective m2-antagonist and a peripheral non-selective antagonist for treating hypocholinergic disorders |
| SG10202007787RA (en) * | 2015-09-28 | 2020-09-29 | Genentech Inc | Therapeutic compounds and methods of use thereof |
| TW202317546A (zh) | 2021-07-09 | 2023-05-01 | 美商普萊克斯姆公司 | 調節ikzf2之芳基化合物及醫藥組合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD113545A5 (enExample) * | 1973-03-30 | 1975-06-12 | ||
| DE3064285D1 (en) * | 1979-09-28 | 1983-08-25 | Beecham Group Plc | Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them |
| AU609232B2 (en) * | 1987-12-14 | 1991-04-26 | Beecham Group Plc | Novel indane derivatives possessing smooth muscle relaxant activity |
| DK286990D0 (da) * | 1990-12-04 | 1990-12-04 | Lundbeck & Co As H | Indanderivater |
| CZ287406B6 (cs) * | 1991-11-05 | 2000-11-15 | Smithkline Beecham Corporation | Indanové a indenové deriváty, způsob jejich výroby a farmaceutické prostředky s jejich obsahem |
| WO1994012493A1 (en) * | 1992-11-25 | 1994-06-09 | Sandoz, Ltd. | 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals |
-
1997
- 1997-06-26 AU AU34953/97A patent/AU717431B2/en not_active Ceased
- 1997-06-26 JP JP10504196A patent/JP2000514060A/ja not_active Ceased
- 1997-06-26 DE DE69715865T patent/DE69715865T2/de not_active Expired - Fee Related
- 1997-06-26 IL IL12785897A patent/IL127858A0/xx unknown
- 1997-06-26 CA CA002258044A patent/CA2258044C/en not_active Expired - Fee Related
- 1997-06-26 KR KR1019980710811A patent/KR20000022380A/ko not_active Withdrawn
- 1997-06-26 WO PCT/US1997/010696 patent/WO1998000412A1/en not_active Ceased
- 1997-06-26 EP EP97931281A patent/EP0912534B1/en not_active Expired - Lifetime
- 1997-06-26 ES ES97931281T patent/ES2179353T3/es not_active Expired - Lifetime
- 1997-06-26 HU HU9904167A patent/HUP9904167A3/hu unknown
- 1997-06-26 AT AT97931281T patent/ATE224884T1/de not_active IP Right Cessation
- 1997-06-26 NZ NZ333322A patent/NZ333322A/en unknown
-
2008
- 2008-07-28 JP JP2008194199A patent/JP2009040778A/ja active Pending